Citius Pharmaceuticals Inc (NAS:CTXR)
$ 0.4783 0.033 (7.35%) Market Cap: 86.44 Mil Enterprise Value: 63.59 Mil PE Ratio: 0 PB Ratio: 1.03 GF Score: 32/100

Citius Pharmaceuticals Inc Corporate Analyst Meeting Transcript

Dec 06, 2020 / NTS GMT
Operator

This is the eHealth Radio Network, your source for health advice on-demand. And now your host, Eric Michaels.

Eric Michaels
eHealth Radio Network - Moderator

Thanks for joining us once again here on the eHealth Radio Network. This is your host, Eric Michaels. eHealth Radio gives you the most current health information, news, and advice featuring some of the leading innovators in healthcare and wellness, who are changing healthcare, as we know it. For more eHealth Radio reports, we invite you to visit our main radio channel site at ehealthradionetwork.com.

Today, we're speaking with both Mr. Myron Holubiak, the President and CEO of Citius Pharmaceuticals; and Mr. Leonard Mazur, Chairman of the Board at Citius Pharmaceuticals, a specialty late-stage pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infectives and cancer care. And gentlemen, thanks for joining us here today on the program.

Myron Holubiak
Citius Pharmaceuticals, Inc. - CEO

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot